NMS is a global, integrated biopharmaceutical company focused on the discovery and development of innovative oncology therapies. With affiliates in Nerviano (Italy), Boston (USA), and Shanghai (China), NMS leverages deep expertise in drug discovery and translational medicine to advance a pipeline of novel candidates from bench to bedside.
Looking for a particular NMS Group employee's phone or email?
The NMS Group annual revenue was $11.5 million in 2026.
Hugues Dolgos is the CEO of NMS Group.
26 people are employed at NMS Group.
NMS Group is based in Nerviano, Mi.
The NAICS codes for NMS Group are [3254, 325, 32, 32541].
The SIC codes for NMS Group are [283, 28].